Effects of Positive End-expiratory Pressure and Tidal Volume on Fluid Responsiveness of Acute Respiratory Distress Syndrome
1 other identifier
observational
30
1 country
1
Brief Summary
Fluid responsiveness (FR)refers to the ability of heart to increase its stroke volume in response to volume load.Low tidal volume and high PEEP exerts contrast effect on the prediction of fluid responsiveness, the aim of this study is to compare the relative predicting power of the dynamic preload indicator (PPV, SVV), passive leg raising test, and pleth variability index (PVI) on the fluid responsiveness of acute respiratory distress syndrome ventilated with various PEEP levels or various tidal volumes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2012
CompletedFirst Posted
Study publicly available on registry
October 30, 2012
CompletedStudy Start
First participant enrolled
November 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedDecember 3, 2012
November 1, 2012
1.7 years
October 26, 2012
November 30, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
increase of cardiac output after volume expansion
Patients are classified to be volume expansion responders or nonresponders according to whether the volume expansion induced cardiac index increase at the end of hydroxyethyl starch infusion is ≧15% or \< 15% of baseline cardiac index.
4 hours
Study Arms (1)
ARDS with acute circulatory failure
acute respiratory distress syndrome with acute circulatory failure with infusion of 6% tetrastarch for a total of 500ml
Interventions
Eligibility Criteria
mechanically ventilated ALL/ARDS patients conforming to the American European Consensus Conference criteria with acute circulatory failure for whom the attending clinician had decided to administer fluid will be enrolled.This decision was based on the presence of at least one clinical sign of inadequate tissue perfusion in the absence of contraindication for fluid infusion.
You may qualify if:
- systolic blood pressure\< 9 mmHg(or a decrease \> 50 mmHg in previously hypertensive patients)
- need of vasopressive drugs(dopamine \> 5 ug/Kg/min or norepinephrine)
- urine output\<0.5 mL/Kg/hr for at least 2 hrs
- tachycardia (heart rate \>100/min)
- presence of skin mottling.
You may not qualify if:
- patient with spontaneous respiratory activity
- cardiac arrhythmia
- known intracardiac shunt
- contraindication for passive leg raising(PLR),e.g.,pelvic trauma
- unstable spine injuries or leg amputation
- hemodynamic instability during the procedure,defined by a variation in heart rate or blood pressure of\>10%over the 15-min period before starting the protocol
- Patients of renal failure necessitate renal replacement therapy will be excluded also.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung Memorial Hospital
Taipei, Taiwan, 10507, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chung-Chi Huang, MD
Chang Gung Memorial Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Department of Respiratory Therapy, Chang Gung University
Study Record Dates
First Submitted
October 26, 2012
First Posted
October 30, 2012
Study Start
November 1, 2012
Primary Completion
July 1, 2014
Last Updated
December 3, 2012
Record last verified: 2012-11